Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $152.5000 (1.67%) ($145.0000 - $160.0000) on Thu. Apr. 19, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.18% (three month average) | RSI | 22 | Latest Price | $152.5000(1.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.9% a day on average for past five trading days. | Weekly Trend | CAPR declines -12.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -3.09% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.09% (StdDev 6.18%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
1 - 5 Day Possible Target | $121.31(-20.45%) | Resistance Level | $189.06 | 5 Day Moving Average | $153(-0.33%) | 10 Day Moving Average | $153.6(-0.72%) | 20 Day Moving Average | $189.06(-19.34%) | To recent high | -47.4% | To recent low | 5.2% | Market Cap | $3.004b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |